Beta-Blockers in the Management of Capillary Haemangiomas in Infants JCG0084 v3.1
Preview
Overview
This is a joint Trust document to guide the selection of patients with rapidly expanding capillary haemangiomas strawberry naevi for treatment with propranolol. To offer guidance to the pre-treatment assessment dosage schedule and monitoring required to facilitate safe initiation of such treatment.
Categories
ClinicalReference
Date Uploaded
21.01.2022Date Review
20.01.2025File Size
178KbClinical Guidelines
This guideline has been approved by the Trust's Clinical Guidelines Assessment Panel as an aid to the diagnosis and management of relevant patients and clinical circumstances. Not every patient or situation fits neatly into a standard guideline scenario and the guideline must be interpreted and applied in practice in the light of prevailing clinical circumstances, the diagnostic and treatment options available and the professional judgement, knowledge and expertise of relevant clinicians. It is advised that the rationale for any departure from relevant guidance should be documented in the patient's case notes.The Trust's guidelines are made publicly available as part of the collective endeavour to continuously improve the quality of healthcare through sharing medical experience and knowledge. The Trust accepts no responsibility for any misunderstanding or misapplication of this document.